RxDoctor Payments Data

Michael Ludwig, MD

Physical Medicine & Rehabilitation · Coeur D Alene, IDNPI 1245330208

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 18 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 6 manufacturers reported payments, led by Pacira Therapeutics, Inc. at 59.1% of the total. Reporting peaked in 2019 at $210 and has fallen 91.7% since, to $17 in 2025.

$529in general payments, 2019–2025

Across 18 payments — averaging $29.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pacira Therapeutics, Inc.$313
  • Zimvie Inc.$134
  • Pfizer$26
  • Abbott$22
  • Fidia Pharma USA Inc.$17
  • Pacira Pharmaceuticals Incorporated$16

What the payments were for

  • Food & beverage$529100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$529 in reported general payments places this provider in the 55th percentile of 38 physical medicine & rehabilitation providers in Idaho.

See all physical medicine & rehabilitation providers in Idaho

Medicare billing

Part B allowed, 2024
$128,133
Medicare patients
331
Services billed
2,173

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin16$254
Tramadol Hcl32$90

Paid to pharmacies, not to this prescriber.

Other physical medicine & rehabilitation in Coeur D Alene

See the full list for Idaho

Where these figures come from

Is this you, or does something look wrong? →